A proliferation-inducing ligand sustains the proliferation of human naïve (CD27−) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen

Abstract

Long-lived plasma cells (PCs) contribute to humoral immunity through an undefined mechanism. Memory B cells, but not human naïve B cells, can be induced to differentiate into long-lived PCs in vitro. Because evidence links a proliferation-inducing ligand (APRIL), a tumor necrosis factor family member, to the ability of bone marrow to mediate long-term PC survival, we reasoned that APRIL influences the proliferation and differentiation of naïve B cells. We describe here the development of a simple cell culture system that allowed us to show that APRIL sustained the proliferation of naïve human B cells and induced them to differentiate into long-lived PCs. Blocking the transmembrane activator and calcium modulator and cyclophilin ligand interactor or B-cell mature antigen shows they were required for the differentiation of naïve B cells into long-lived PCs in vitro. Our in vitro culture system will reveal new insights into the biology of long-lived PCs.

Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children

“…Also JAK-STAT signaling and TLR oriented stimulation pathways were upregulated ( Figure 5 ) in patients able to respond to TIV. It is important to mention that other genes, such as IL21 and TNSF13 (APRIL), previously reported to be crucial in the T-B cell interaction ( 23 , 24 ), resulted informative after in vitro stimulation to define responders. According to our previous analysis ( 15 ) these data may suggest that the functional expression of these genes after in vitro stimulation is able to predict the ability of these cells to activate a functional cascade which sustain an effective humoral response after vaccination.…”

Bone Marrow Mesenchymal Stem Cells Enhance the Differentiation of Human Switched Memory B Lymphocytes into Plasma Cells in Serum-Free Medium

“…These culture models support the differentiation of naive [45–48] or activated B lymphocytes [49–51] upon CD40 activation in the presence of a cocktail of cytokines such as IL-4, IL-10, and IL-6. Such in vitro generated plasma cells are often close to a short-lived phenotype, showing very high levels of Ig secretion and a limited capacity to proliferate.…”

Emerging role of CAR T cell therapy in multiple myeloma

“…BCMA is selectively generated during plasma cell differentiation and plays a regulatory role in plasma cell survival. Because BCMA RNA is detected universally in multiple myeloma cells and BCMA protein is detected on the surface of plasma cells, it is an excellent target for CAR‐T cell specificity …”